NCT04094025View on ClinicalTrials.gov

Irritation and Sensitization Study of d-Amphetamine Transdermal System

PHASE1CompletedINTERVENTIONAL

Enrollment

229

Participants

Timeline

Start Date

December 2, 2019

Primary Completion Date

May 16, 2020

Study Completion Date

May 16, 2020

Conditions

Cumulative Irritation and Sensitization

Interventions

DRUG

dATS

d-Amphetamine Transdermal System

Trial Locations (1)

07310

Noven Pharmaceuticals, Jersey City

Sponsors

Lead Sponsor

Noven Therapeutics

All Listed Sponsors

lead

Noven Therapeutics

INDUSTRY